![](/images/general/no_picture/200_user.png)
Chandrika Prasad
Examiner (ID: 17499, Phone: (571)272-2099 , Office: P/2831 )
Most Active Art Unit | 2839 |
Art Unit(s) | 2833, 2839, 2831 |
Total Applications | 2897 |
Issued Applications | 2445 |
Pending Applications | 55 |
Abandoned Applications | 397 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6697476
[patent_doc_number] => 20030109670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Cone snail peptides'
[patent_app_type] => new
[patent_app_number] => 10/072602
[patent_app_country] => US
[patent_app_date] => 2002-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21587
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109670.pdf
[firstpage_image] =>[orig_patent_app_number] => 10072602
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/072602 | Cone snail peptides | Feb 10, 2002 | Abandoned |
Array
(
[id] => 1137677
[patent_doc_number] => 06780614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-24
[patent_title] => 'Modified factor VIII cDNA and its use for the production of factor VIII'
[patent_app_type] => B2
[patent_app_number] => 10/067894
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4193
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067894 | Modified factor VIII cDNA and its use for the production of factor VIII | Feb 7, 2002 | Issued |
10/049745 | Proteases and protease inhibitors | Jan 29, 2002 | Abandoned |
09/787678 | Human chaperone proteins | Jan 17, 2002 | Abandoned |
Array
(
[id] => 6536181
[patent_doc_number] => 20020193302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis'
[patent_app_type] => new
[patent_app_number] => 10/051044
[patent_app_country] => US
[patent_app_date] => 2002-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12872
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051044 | Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis | Jan 13, 2002 | Abandoned |
10/020095 | Novel human alpha macroglobulin family proteins and polynucleotides encoding the same | Dec 13, 2001 | Abandoned |
10/022710 | Novel human thrombospondin repeat proteins and polynucleotides encoding the same | Dec 12, 2001 | Abandoned |
Array
(
[id] => 7034171
[patent_doc_number] => 20050032681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'HUMAN ANTITHROMBIN IIIS AND METHODS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 10/014658
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17546
[patent_no_of_claims] => 138
[patent_no_of_ind_claims] => 46
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014658 | Human antithrombin IIIs and methods related thereto | Dec 10, 2001 | Issued |
Array
(
[id] => 5923964
[patent_doc_number] => 20020115833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Erythropoietin conjugates'
[patent_app_type] => new
[patent_app_number] => 10/014363
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9656
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014363 | Erythropoietin conjugates | Dec 10, 2001 | Issued |
Array
(
[id] => 7290742
[patent_doc_number] => 20040110675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Mutant human factor ix with an increased resistance to inhibition by heparin'
[patent_app_type] => new
[patent_app_number] => 10/416952
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20530
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110675.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416952 | Mutant human factor IX with an increased resistance to inhibition by heparin | Nov 12, 2001 | Issued |
Array
(
[id] => 7313390
[patent_doc_number] => 20040033566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Modified factor viia'
[patent_app_type] => new
[patent_app_number] => 10/415963
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7902
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033566.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415963 | Modified factor VIIa | Nov 8, 2001 | Issued |
Array
(
[id] => 1134750
[patent_doc_number] => 06784154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-31
[patent_title] => 'Method of use of erythropoietin to treat ischemic acute renal failure'
[patent_app_type] => B2
[patent_app_number] => 10/003352
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6094
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/784/06784154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10003352
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/003352 | Method of use of erythropoietin to treat ischemic acute renal failure | Oct 31, 2001 | Issued |
Array
(
[id] => 5874587
[patent_doc_number] => 20020049161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Pharmaceutical combination preparations containing erythropoietin and iron preparations'
[patent_app_type] => new
[patent_app_number] => 09/984268
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6592
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049161.pdf
[firstpage_image] =>[orig_patent_app_number] => 09984268
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/984268 | Pharmaceutical combination preparations containing erythropoietin and iron preparations | Oct 28, 2001 | Abandoned |
Array
(
[id] => 1082970
[patent_doc_number] => 06833352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-21
[patent_title] => 'Coagulation factor Viia composition'
[patent_app_type] => B2
[patent_app_number] => 10/026032
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 2
[patent_no_of_words] => 5978
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/833/06833352.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026032 | Coagulation factor Viia composition | Oct 24, 2001 | Issued |
Array
(
[id] => 6032861
[patent_doc_number] => 20020019036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Von willebrand factor derivatives and methods of isolating proteins that bind to von willebrand factor'
[patent_app_type] => new
[patent_app_number] => 09/967937
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5216
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019036.pdf
[firstpage_image] =>[orig_patent_app_number] => 09967937
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/967937 | Von willebrand factor derivatives and methods of isolating proteins that bind to von willebrand factor | Oct 1, 2001 | Abandoned |
Array
(
[id] => 6472824
[patent_doc_number] => 20020151471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Factor VII glycoforms'
[patent_app_type] => new
[patent_app_number] => 09/969358
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10917
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151471.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969358
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969358 | Factor VII glycoforms | Oct 1, 2001 | Abandoned |
Array
(
[id] => 6544510
[patent_doc_number] => 20020137673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Factor VII glycoforms'
[patent_app_type] => new
[patent_app_number] => 09/969357
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10999
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137673.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969357
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969357 | Factor VII glycoforms | Oct 1, 2001 | Issued |
Array
(
[id] => 1151379
[patent_doc_number] => 06770744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-03
[patent_title] => 'Modified factor VIII'
[patent_app_type] => B2
[patent_app_number] => 09/957641
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 22770
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770744.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957641
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957641 | Modified factor VIII | Sep 18, 2001 | Issued |
Array
(
[id] => 6650970
[patent_doc_number] => 20030104996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'L-methionine as a stabilizer for NESP/EPO in HSA-free formulations'
[patent_app_type] => new
[patent_app_number] => 09/945517
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5258
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945517
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945517 | L-methionine as a stabilizer for NESP/EPO in HSA-free formulations | Aug 29, 2001 | Abandoned |
Array
(
[id] => 6561230
[patent_doc_number] => 20020164739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Cell calcification supressing proteins, and genes of the proteins'
[patent_app_type] => new
[patent_app_number] => 09/902772
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5273
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164739.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902772
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902772 | Cell calcification supressing proteins, and genes of the proteins | Jul 11, 2001 | Abandoned |